MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism
Heather Manna, VP, Global Regulatory Affairs, Inceptua Early Access, answers questions about Real World Data and Early Access.
We asked Mark Bainbridge, Sr. Director, Inceptua Early Access, to answer 5 quick questions about the important role Early Access is playing…
As we are strengthening our offering and presence in China, we are delighted to present Ryan Zhang as Regional Director Business Development.
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism
Apealea is the first Cremophor-free formulation of paclitaxel approved in combination with carboplatin for ovarian cancer.
Heather Manna joins the Inceptua Early Access business unit as Vice President Global Regulatory Affairs
